9413 Phase II trial of adjuvant imatinib mesylate after resection of localized, primary high risk gastrointestinal stromal tumour (GIST) in Japan

✍ Scribed by Nishida, T.; Kanda, T.; Wada, N.; Kobayashi, O.; Yamamoto, M.; Sawaki, A.; Boku, N.; Koseki, M.; Doi, T.; Toh, Y.

• Book ID: 122018128
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 48 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)72001-4